Ethnic differences in propofol and fentanyl response: A comparison among Caucasians, Kenyan Africans and Brazilians

European Journal of Anaesthesiology

Volumn 21, Issue 4, 2004, Pages 314-319

  Ortolani, Oreste ^a,e   Conti, A ^b   Ngumi, Z W ^c   Texeira, L ^d   Olang, P ^c   Amani, I ^c   Medrado, V C ^d  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d Chefia de Anesthesia   (Brazil)

^e NONE   (Italy)

Author keywords

Anaesthetics, intravenous, propofol; Analgesics, opioid, fentanyl; Anthropology, physical, racial stocks, Caucasoid race, Negroid race; Cytochrome P450 enzyme system; Pharmacogenetics; Pharmacokinetics

Indexed keywords

ANESTHETIC AGENT; FENTANYL; PROPOFOL;

ADULT; ANESTHESIA LEVEL; ANESTHETIC RECOVERY; ARTICLE; BISPECTRAL INDEX; BRAZIL; CAUCASIAN; CLINICAL ARTICLE; COMPARATIVE STUDY; DRUG INFUSION; DRUG SENSITIVITY; ETHNIC DIFFERENCE; FEMALE; HUMAN; MALE; NEGRO; VERBALIZATION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANESTHESIA RECOVERY PERIOD; ANESTHETICS, INTRAVENOUS; BLOOD PRESSURE; BRAZIL; ELECTROENCEPHALOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FENTANYL; HEART RATE; HUMANS; ITALY; KENYA; MALE; MIDDLE AGED; OXYGEN; PROPOFOL; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 1842713311     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0265021504004119     Document Type: Article

References (13)

1. Xie HG, Kim RB, Wood AJ, Stein CM. Molecular basis of ethnic differences in drug disposition and response. Annu Rev Pharmacol Toxicol 2001; 41: 815-850.
2. Ortolani O, Conti A, Sall-Ka B, et al. The recovery of Senegalese African blacks from intravenous anesthesia with propofol and remifentanil is slower than that of Caucasians. Anesth Analg 2001; 93: 1222-1226.
3. Rampil IJ. A primer for EEG signal processing in anesthesia. Anesthesiology 1998; 89: 980-1002.
4. Bradford LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics 2002; 3: 229-243.
5. Wennerholm A, Johansson I, Hidestrand M, Bertilsson L, Gustafsson LL, Ingelman-Sundberg M. Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity. Pharmacogenetics 2001; 11: 417-427.
6. Isaza CA, Henao J, Lopez AM, Cacabelos R. Isolation, sequence and genotyping of the drug metabolizer CYP2D6 gene in the Colombian population. Meth Find Exp Clin Pharmacol 2000; 22: 695-705.
7. Sutherland L, Ebner T, Burchell B. The expression of UDP-glucuronosyltransferases of the UGT1 family in human liver and kidney and in response to drugs. Biochem Pharmacol 1993; 45: 295-301.
8. Simons PJ, Cockshott ID, Douglas EJ, Gordon EA, Knott S, Rouane RJ. Species differences in blood profiles, metabolism and excretion of 14C-propofol after intravenous dosing to rat, dog and rabbit. Xenobiotica 1991; 21: 1243-1256.
9. Court MH, Duan SX, Hesse LM, Venkatakrishnan K, Greenblatt DJ. Cytochrome P450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes. Anesthesiology 2001; 94: 110-119.
10. Favetta P, Degoute CS, Perdix JP, Dufresne C, Boulieu R, Guitton J. Propofol metabolites in man following induction and maintenance. Br J Anaesth 2002; 88: 653-658.
11. Vuyk J. Clinical interpretation of pharmacokinetic and pharmacodynamic propofol-opioid interactions. Acta Anaesthesiol Belg 2001; 52:445-451.
12. Azevedo ES, Fortuna CM, Silva KM, et al. Spread and diversity of human populations in Bahia, Brazil. Hum Biol 1982; 54: 329-341.
13. Azevedo ES. Subgroup studies of black admixture within a mixed population of Bahia, Brazil. Ann Hum Genet 1980; 44: 55-60.